Common Medications May Delay Parkinson’s Onset - Report - MDSpire
Advertisement
Common Medications May Delay Parkinson’s Onset
In a new Cedars-Sinai study of Parkinson’s disease patients, those who had taken common medications to control pain, blood pressure, diabetes or cholesterol saw their symptoms begin years later than patients who never took these medications.
Clinical Report: Common Medications May Delay Parkinson’s Onset
Overview
A Cedars-Sinai study suggests that common medications may delay the onset of Parkinson's disease symptoms. Patients taking nonsteroidal anti-inflammatory drugs, statins, and beta blockers experienced symptoms an average of 8.6 to 9.6 years later than those who did not use these medications.
Background
Parkinson's disease is a progressive neurodegenerative disorder characterized by motor symptoms such as tremors and balance issues. The onset of Parkinson's is influenced by age and potentially modifiable risk factors, including inflammation. Understanding the role of common medications in delaying symptom onset could inform treatment strategies and improve patient outcomes.
Data Highlights
Medication Type
Average Years Delayed Onset
Nonsteroidal Anti-Inflammatory Drugs
8.6
Statins
9.3
Beta Blockers
9.6
Key Findings
Patients taking nonsteroidal anti-inflammatory drugs had an average onset delay of 8.6 years.
Statin users experienced an average delay of 9.3 years in symptom onset.
Beta blocker users had symptoms appear 9.6 years later than non-users.
Inflammation control may play a role in delaying Parkinson's disease onset.
Further research is needed to confirm these findings in larger, prospective studies.
Clinical Implications
Healthcare professionals should consider the potential impact of common medications on the onset of Parkinson's disease when evaluating patient histories. While these findings are promising, further studies are essential to establish causation and inform clinical practice.
Conclusion
This study highlights a potential link between common medications and delayed onset of Parkinson's disease, warranting further investigation to explore their therapeutic implications.
Baptist Health Foundation announced that it has received a $2 million donation from Anthony and Joyce Esernia to establish a new endowed chair at Baptist Health Miami Neuroscience Institute.
